Effect of lysophosphatidylcholine on vasomotor functions of porcine coronary arteries

Journal of Surgical Research

Volumn 126, Issue 2, 2005, Pages 182-188

  Safaya, Rakesh ^a   Chai, Hong ^a   Kougias, Panagiotis ^a   Lin, Peter ^a   Lumsden, Alan ^a   Yao, Qizhi ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary arteries; Endothelial dysfunction; Endothelial nitric oxide synthase; Lysophosphatidylcholine; Oxidative stress; Porcine; Superoxide anion

Indexed keywords

ANTIOXIDANT; AVIDIN; BIOTIN; BRADYKININ; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LUCIGENIN; LYSOPHOSPHATIDYLCHOLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXIDASE; SELENOMETHIONINE; SUPEROXIDE;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; IMMUNOREACTIVITY; MYOGRAPHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REDUCTION; VASODILATATION;

ANIMALS; ANTIOXIDANTS; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; LYSOPHOSPHATIDYLCHOLINES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; SELENOMETHIONINE; SUPEROXIDES; SWINE; VASODILATION; VASOMOTOR SYSTEM;

EID: 20344365075     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2005.01.015     Document Type: Conference Paper

References (43)

1. J.L. Breslow Cardiovascular disease burden increases, NIH funding decreases Nat. Med. 3 1997 600
2. P.C. Choy, Y.L. Siow, D. Mymin, O. Karmin Lipids and atherosclerosis Biochem. Cell. Biol. 82 2004 212
3. R. Ross Atherosclerosis - an inflammatory disease N. Engl. J. Med. 340 1999 115
4. N. Sattar Inflammation and endothelial dysfunction intimate companions in the pathogenesis of vascular disease? Clin. Sci. 106 2004 443
5. K.J. Williams, I. Tabas The response-to-retention hypothesis of early atherogenesis Arterioscler. Thromb. Vasc. Biol. 15 1995 551
6. A. Stiko, J. Regnstrom, P.K. Shah, B. Cercek, J. Nilsson Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis Arterioscler. Thromb. Vasc. Biol. 16 1996 194
7. O.W. Portman, M. Alexander Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media effect of nutritionally induced atherosclerosis J. Lipid. Res. 10 1969 158
8. S. Yla-Herttuala, W. Palinski, M.E. Rosenfeld, S. Parthasarathy, T.E. Carew, S. Butler, J.L. Witztum, D. Steinberg Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J. Clin. Invest. 84 1989 1086
9. M. Yokoyama, K. Hirata, R. Miyake, H. Akita, Y. Ishikawa, H. Fukuzaki Lysophosphatidylcholine Essential role in the inhibition of endothelium- dependent vasorelaxation by oxidized low density lipoprotein Biochem. Biophys. Res. Commun. 168 1990 301
10. J.K. Liao, W.S. Shin, W.Y. Lee, S.L. Clark Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase J. Biol. Chem. 270 1995 319
11. K. Kugiyama, S.A. Kerns, J.D. Morrisett, R. Roberts, P.D. Henry Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins Nature 344 1990 160
12. N. Kume, M.I. Cybulsky, M.A. Gimbrone Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells J. Clin. Invest. 90 1992 1138
13. S. Sugiyama, K. Kugiyama, M. Ohgushi, K. Fujimoto, H. Yasue Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries Role of protein kinase C Circ. Res. 74 1994 565
14. M.T. Quinn, S. Parthasarathy, D. Steinberg Lysophosphatidylcholine A chemotactic factor for human monocytes and its potential role in atherogenesis Proc. Natl. Acad. Sci. USA 85 1988 2805
15. T. Watanabe, R. Pakala, T. Katagiri, C.R. Benedict Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation J. Cardiovasc. Pharmacol. 39 2002 449
16. G.N. Schrauzer Selenomethionine A review of its nutritional significance, metabolism and toxicity J. Nutr. 130 2000 1653
17. G.E. Arteel, K. Briviba, H. Sies Protection against peroxynitrite FEBS Lett. 445 1999 226
18. L. Chen, B. Liang, D.E. Froese, S. Liu, J.T. Wong, K. Tran, G.M. Hatch, D. Mymin, E.A. Kroeger, R.Y. Man, P.C. Choy Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients Effect of lysophosphatidylcholine composition on vascular relaxation J. Lipid. Res. 38 1997 546
19. S. Parthasarathy, U.P. Steinbrecher, J. Barnett, J.L. Witztum, D. Steinberg Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein Proc. Natl. Acad. Sci. USA 82 1985 3000
20. U.P. Steinbrecher, S. Parthasarathy, D.S. Leake, J.L. Witztum, D. Steinberg Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids Proc. Natl. Acad. Sci. USA 81 1984 3883
21. O. Fourcade, F. Le Balle, J. Fauvel, M.F. Simon, H. Chap Regulation of secretory type-II phospholipase A2 and of lysophosphatidic acid synthesis Adv. Enzyme Regul. 38 1998 99
22. J.A. Glomset The mechanism of the plasma cholesterol esterification reaction Plasma fatty acid transferase Biochim. Biophys. Acta. 65 1962 128
23. I.C. Wells, G. Peitzmeier, J.K. Vincent Lecithin Cholesterol acyltransferase and lysolecithin in coronary atherosclerosis Exp. Mol. Pathol. 45 1986 303
24. K.H. Benzuly, R.C. Padgett, S. Kaul, D.J. Piegors, M.L. Armstrong, D.D. Heistad Functional improvement precedes structural regression of atherosclerosis Circulation 89 1994 1810
25. K. Hirata, N. Miki, Y. Kuroda, T. Sakoda, S. Kawashima, M. Yokoyama Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells Circ. Res. 76 1995 958
26. D.E. Froese, J. McMaster, R.Y. Man, P.C. Choy, E.A. Kroeger Inhibition of endothelium-dependent vascular relaxation by lysophosphatidylcholine Impact of lysophosphatidylcholine on mechanisms involving endothelium-derived nitric oxide and endothelium derived hyperpolarizing factor Mol. Cell. Biochem. 197 1999 1
27. Y. Miwa, K. Hirata, S. Kawashima, H. Akita, M. Yokoyama Lysophosphatidylcholine inhibits receptor-mediated Ca2+ mobilization in intact endothelial cells of rabbit aorta Arterioscler. Thromb. Vasc. Biol. 17 1997 1561
28. T. Murohara, K. Kugiyama, M. Ohgushi, S. Sugiyama, Y. Ohta, H. Yasue LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation Am. J. Physiol. 267 1994 H2441
29. J.X. Rong, J.W. Berman, M.B. Taubman, E.A. Fisher Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 22 2002 1617
30. T. Watanabe, S. Koba, T. Katagiri, R. Pakala, C.R. Benedict Lysophosphatidylcholine potentiates the mitogenic effect of various vasoactive compounds on rabbit aortic smooth muscle cells Jpn. Heart J. 43 2002 409
31. J. Dulak, A. Jozkowicz, W. Dichtl, H. Alber, S.P. Schwarzacher, O. Pachinger, F. Weidinger, J. Dulakk Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation Atherosclerosis 159 2001 325
32. C.C. Hsieh, M.H. Yen, H.W. Liu, Y.T. Lau Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells in comparison with oxidized LDL Atherosclerosis 151 2000 481
33. J.S. Beckman, W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite The good, the bad, and ugly Am. J. Physiol. 271 1996 C1424
34. Z.S. Nedeljkovic, N. Gokce, J. Loscalzo Mechanisms of oxidative stress and vascular dysfunction Postgrad. Med. J. 79 2003 195
35. M. Shibanuma, T. Kuroki, K. Nose Superoxide as a signal for increase in intracellular pH J. Cell. Physiol. 136 1988 379
36. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells AP-1 as secondary antioxidant-responsive factor EMBO. J. 12 1993 2005
37. Y. Chen, S. Morimoto, S. Kitano, E. Koh, K. Fukuo, B. Jiang, S. Chen, O. Yasuda, A. Hirotani, T. Ogihara Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells Atherosclerosis 112 1995 69
38. L.L. Stoll, A.A. Spector Lysophosphatidylcholine causes cGMP-dependent verapamil-sensitive Ca2+ influx in vascular smooth muscle cells Am. J. Physiol. 264 1993 C885
39. P. Ganz, J.A. Vita Testing endothelial vasomotor function nitric oxide, a multipotent molecule Circulation 108 2003 2049
40. P.W. Shaul Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis J. Physiol. 547 2003 21
41. C.P. Leeson, A.D. Hingorani, M.J. Mullen, N. Jeerooburkhan, M. Kattenhorn, T.J. Cole, D.P. Muller, A. Lucas, S.E. Humphries, J.E. Deanfield Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function Circ. Res. 90 2002 1153
42. E. Millanvoye-Van Brussel, G. Topal, A. Brunet, T. Do Pham, V. Deckert, F. Rendu, M. David-Dufilho Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2 Biochem. J. 380: 2004 533
43. B. Thors, H. Halldorsson, G.D. Clarke, G. Thorgeirsson Inhibition of Akt phosphorylation by thrombin, histamine and lysophosphatidylcholine in endothelial cells Differential role of protein kinase C Atherosclerosis 168 2003 245